PHBI vs LLY: Which Stock is Better?
Side-by-side comparison of Pharmagreen Biotech Inc. and Eli Lilly & Co in 2026
PHBI
Pharmagreen Biotech Inc.
$0.00
LLY
Eli Lilly & Co
$927.03
Key Metrics Comparison
| Metric | PHBI | LLY | Winner |
|---|---|---|---|
| Market Cap | $0.83M | $829.71B | LLY |
| P/E Ratio | N/A | 40.38 | LLY |
| EPS (TTM) | $N/A | $22.96 | LLY |
| Revenue Growth | -0.3% | 0.4% | LLY |
| Gross Margin | 44.9% | 83.0% | LLY |
Analyze PHBI
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHBI or LLY a better investment?
Comparing PHBI and LLY: Pharmagreen Biotech Inc. has a market cap of $0.83M while Eli Lilly & Co has $829.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHBI and LLY?
PHBI (Pharmagreen Biotech Inc.) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHBI or LLY?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHBI or LLY?
LLY has higher revenue growth at 0.4% vs -0.3% for PHBI.
Which company is more profitable: PHBI or LLY?
Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 44.9% for PHBI.
Which is the larger company: PHBI or LLY?
Eli Lilly & Co (LLY) is larger with a market cap of $829.71B compared to $0.83M for PHBI.
Should I buy PHBI or LLY in 2026?
Both PHBI and LLY have investment merit. PHBI trades at $0.00 while LLY trades at $927.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHBI and LLY stock?
Key differences: Market Cap ($0.83M vs $829.71B), P/E Ratio (N/A vs 40.4x), Revenue Growth (-0.3% vs 0.4%), Gross Margin (44.9% vs 83.0%).